Show Summary Details
Page of

Adherence to Psychotherapy and Pharmacotherapy for Anxiety Disorders 

Adherence to Psychotherapy and Pharmacotherapy for Anxiety Disorders
Adherence to Psychotherapy and Pharmacotherapy for Anxiety Disorders

Alyson K. Zalta

, Elizabeth C. Kaiser

, Sheila M. Dowd

, and Mark H. Pollack

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 15 August 2020

Problems with adherence are common in the treatment of anxiety disorders and diminish the effectiveness of treatment. In this chapter we describe the types of adherence issues that arise in first-line treatments for anxiety disorders and the factors that contribute to these problems. We then describe strategies for improving adherence to treatment recommendations and highlight the role of technology in offering new adherence-promoting interventions. Overall, the literature on adherence in the treatment of anxiety disorders is sparse, suggesting that further research is needed to establish the most effective approaches to enhancing adherence. However, existing research findings point to the fact that adherence is multidetermined and that a combination of intervention strategies is likely to be most effective in improving adherence.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.